Kingdon Capital Management, L.L.C. Curis Inc Transaction History

Kingdon Capital Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.74 - $15.01 $444,000 - $9.01 Million	600,000 Added 31.18%	2,524,424 $1.77 Million
Q2 2022 Aug 15, 2022	BUY	$0.71 - $2.43 $240,991 - $824,800	339,424 Added 21.41%	1,924,424 $1.9 Million
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $648,601 - $1.44 Million	280,780 Added 21.53%	1,585,000 $3.77 Million
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $111,250 - $202,250	25,000 Added 1.95%	1,304,220 $6.21 Million
Q3 2021 Nov 15, 2021	BUY	$6.94 - $8.85 $347,000 - $442,500	50,000 Added 4.07%	1,279,220 $10 Million
Q2 2021 Aug 16, 2021	BUY	$7.45 - $16.27 $9.16 Million - $20 Million	1,229,220 New	1,229,220 $9.92 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.